Many medical procedures require repeated and prolonged access to a patient's vascular system. For example, during dialysis treatment blood may be removed from the body for external filtering and purification, to make up for the inability of the patient's kidneys to carry out that function. In this process, the patient's venous blood is extracted, processed in a dialysis machine and returned to the patient. The dialysis machine purifies the blood by diffusing harmful compounds through membranes, and may add to the blood therapeutic agents, nutrients etc., as required before returning it to the patient's body. Typically the blood is extracted from a source vein (e.g., the vena cava) through a catheter sutured to the skin with a distal needle of the catheter penetrating the source vein.
It is impractical and dangerous to insert and remove the catheter for each dialysis session. Thus, the needle and catheter are generally implanted semi permanently with a distal portion of the assembly remaining within the patient in contact with the vascular system while a proximal portion of the catheter remains external to the patient's body. The proximal end is sealed after each dialysis session has been completed to prevent blood loss and infections. However, even small amounts of blood oozing into the proximal end of the catheter may be dangerous as thrombi can form therein due to coagulation which thrombi may then be introduced into the patient's vascular system when blood flows from the dialysis machine through the catheter in a later session.
A common method of sealing the catheter after a dialysis session is to shut the catheter with a simple clamp. This method is often unsatisfactory because the repeated application of the clamp may weaken the walls of the catheter due to the stress placed on the walls at a single point. In addition, the pinched area of the catheter may not be completely sealed allowing air to enter the catheter which may coagulate any blood present within the catheter. Alternatively, valves have been used at the opening of the catheter in an attempt to prevent leaking through the catheter when the dialysis machine is disconnected. However, the unreliability of conventional valves has rendered them unsatisfactory for extended use.
The present invention is directed to a valve for controlling material flow through a catheter, comprising a first flexible member including a first moveable element, wherein, when the first moveable element is in the open position, material may flow past the first flexible member through a first lumen of the catheter and, when the first moveable element is in the closed position, flow through the first lumen is prevented and a first biasing member coupled to the first flexible member for biasing the first moveable member toward the closed position.
Semi-permanently placed catheters may be useful for a variety of medical procedures which require repeated access to a patient's vascular system in addition to the dialysis treatments mentioned above. For example, chemotherapy infusions may be repeated several times a week for extended periods of time. For safety reasons, as well as to improve the comfort of the patient, injections of these therapeutic agents may be better carried out with an implantable, semi-permanent vascular access catheter. Many other conditions that require chronic venous supply of therapeutic agents, nutrients, blood products or other fluids to the patient may also benefit from implantable access catheters, to avoid repeated insertion of a needle into the patient's blood vessels. Thus, although the following description focuses on dialysis, those skilled in the art will understand that the invention may be used in conjunction with any of a wide variety of procedures which require long term implantation of catheters within the body.
Examples of such implantable catheters include those manufactured by Vaxcel™, such as the Chronic Dialysis Catheter and the Implantable Vascular Access System. These devices typically are inserted under the patient's skin, and have a distal end which includes a needle used to enter a blood vessel. The devices also have a proximal end extending outside the body for connection with an outside line. These semi-permanent catheters may be sutured to the patient's skin to maintain them in place while the patient goes about his or her normal occupations.
After the dialysis or other procedure has been completed, the catheter 10 is disconnected from the dialysis machine, and is left within the patient fluidly coupled to the patient's vascular system. When not connected to a dialysis machine, the catheter 10 is securely sealed to prevent fluids and gases from crossing into the proximal end of catheter 10 by preventing flow in and out of catheter 10 through hubs 18, 20. As would be understood by those skilled in the art, this sealing prevents the risks associated with infections and thrombi which might be experienced if air or other gas or liquid and/or pathogens were to pass into the catheter 10.
As indicated above, although conventional clamps or clips may be used to seal the catheter 10 between medical sessions, over time the wall of the catheter 10 may be damaged in the area to which the clamp or clip is applied. Sealing clamps or clips may also become dislodged during patient activities, increasing the risk of leaks, infections, etc. Placing a clamp on the catheter 10 also increases the bulk of the distal end of the catheter which is exposed outside the patient's body, and may adversely affect patient comfort.
Therefore, the catheter 10 includes one or more self sealing valves along each of the lumens 22, 24 to seal them when not being used during dialysis and other transfusion or infusion sessions. For example, hubs 18, 20 may be used to house one or more valves each of which is designed to seal the corresponding lumen 22, 24 under certain conditions, and to allow passage of fluids under other conditions. For example, in the case of dialysis treatment, the system of valves may seal the catheter 10 when it is not connected to an operating dialysis machine, and may allow both an outflow of non-purified blood and an inflow of purified blood to the patient when an operating dialysis machine is connected thereto.
Preferably, a valve system for use in such semi-permanent catheters should, when in the open position, allow a flow rate therethrough which is sufficient to allow the procedure to be completed in an acceptably short time. When in the closed position, the valve should completely seal the catheter. That is, if the valve requires excessive force to be opened, the flow rate through the catheter may be reduced to the point where the time required for the procedure is unacceptably extended. In addition, a valve system having moving parts of too great a bulk may also result in larger blockages within the catheter or the hub housing the valve thereby reducing the flow rate through the catheter. The mechanism that moves the valve into the open and closed positions may block the flow through the valve if it protrudes into the flow passage, and thus the size and bulk of the mechanism should preferably be minimized to avoid impeding flow through the open valve.
The portion of the valve that moves to the open position must also completely return to the closed position when the session is completed. For example, a pressure sensitive valve may be used, which opens in response to a pressure driving the flow through the catheter. In the case of a dialysis catheter, the valve or valves may open when a pressure generated by the dialysis machine exceeds a predetermined threshold to allow circulation and purification of the patient's blood. When the dialysis machine is turned off and the pressure in the dialysis line is reduced below the threshold, the valve is completely sealed to prevent further flow from and to the patient. Some pressure is also present in the patient line connecting the valve to the patient's vein as a result of the circulation in the patient's vascular system. Each of the valves must therefore be designed so that it will not respond to such pressure variations introduced by the vascular system and will not open unless a pressure above the threshold is generated externally, for example, by a dialysis machine.
The exemplary embodiments according to the present invention described herein obtain both a secure closure of a semi-permanent catheter implanted in a patient when the catheter is not in use and permit a flow passage that is easily opened to allow a sufficient flow rate when access to the vascular system is necessary.
In many applications, the pressure actuated valve system remains open for the entire length of a therapeutic session, which may last a significant amount of time. For example, in the case of a dialysis session, the valve system may remain open for up to four hours at a time, during sessions carried out up to three times a week. The exemplary embodiments of valves according to the present invention provide a seal to the catheter even after being maintained in the open position for prolonged periods of time.
Specific embodiments of the present invention will be described below with reference to the drawings.
In the exemplary embodiment shown in
In one exemplary embodiment the valve element 100 is used in conjunction with dialysis equipment, and movement of movable elements 118 to the open position is prompted by an actuating pressure of a fluid within dialysis lines 30, 32 which may be connected to the hubs 18, 20, respectively, to connect the catheter 10 to a dialysis machine. In particular, an actuating pressure is generated by pumps in the dialysis machine to move the patient's blood between the patient and the filtration equipment. Although the movable elements 118 are formed as flexible flaps, they are formed with a predetermined amount of resilience to allow them to remain in the closed position when not acted upon by the pressure in dialysis lines 30, 32. Specifically, the elements 118 are biased to remain in the closed position abutting one another along edges 120 at all times when they are not acted on by a pressure outside a range of approximately 22 to 44 mmHg. Specifically, as mentioned above, the elements 118 are formed so that the amount of resilience is sufficient to maintain them in the closed position without being forced open by fluid forces generated by natural circulation of the patient's blood. As would be understood by those skilled in the art, the amount of pressure required to open the movable elements 118 is a function of the resilience of the material forming those elements, the size and shape of the slit 112, and the size of the flow passage containing the valve element 100. The details of the geometry of the slit 112 and the movable elements 118 may be selected to obtain the desired characteristics of maximum flow in the open position, and to ensure that valve element 100 seals the flow passage when the pressure is removed.
A stiffening element 114 may be included in valve element 100, to better control the amount of force biasing the movable elements 118 to the closed position. In particular, coupling a stiffening element to an otherwise flexible disk 110 (or forming a stiffening element integrally therewith) provides a valve element 100 including movable elements 118 more resistant to plastic deformation during sessions lasting multiple hours in which the valve element 100 is kept open. An example of a suitable stiffening member is the addition of stiffening ring 114 to the flexible disk 110. The stiffening element 114 may, for example, be formed of a wire embedded within the valve element 100. Of course, those skilled in the art will understand that the stiffening element 114 may be formed of metal, plastic or any substantially rigid material.
In one exemplary embodiment, the stiffening ring 114 may be embedded within the material of the disk 110, to minimize the bulk of the combination. In different embodiments, stiffening elements may be bonded to one or both sides of the valve element 100, depending on the requirements of the use of the valve element 100. The shape of the stiffening elements used in the valve element 100 may also be modified, depending on the desired characteristics of the force urging the movable elements 118 to the closed position. Alternatively, the stiffening elements may be integrally formed with the disk 110.
As indicated above, the maximum flow that can pass through valve element 100 and the ability to close fully when the actuating pressure is removed are important design parameters for the pressure actuated valves described herein. According to embodiments of the invention, these design parameters may be controlled by properly shaping and sizing the slit or slits 112. Selection of the dimensions of the slit 112 results in movable elements 118 having a desired shape and being constrained along selected edges. In the exemplary embodiment shown in
The performance characteristics of the valve element 100 can be further tuned by selecting an appropriate length l of the slit 112. By altering this length l, both the maximum flow rate and the opening/closing performance of the valve element 100 will be changed. For example, increasing the length of the slit 112, other parameters being the same, increases a maximum size of the opening through the flexible disk 110, and makes it easier to displace the movable elements 118 to the open position as they are unconstrained along longer edges 120. For the same reason, the movable elements 118 are subjected to a reduced force biasing them toward the closed position when the actuating pressure is removed. Both the width d and the length l of the slit 112 are selected as a tradeoff between ease/size of the opening and the biasing force closing the valve element 100 after use.
A different exemplary configuration of slits to define the movable elements is shown in
Additional resilient elements may also be used in the exemplary embodiment shown in
Another exemplary embodiment according to the present invention is depicted in
The greater unconstrained length of the sides of the movable element 264 along the slits 262, enables a large flow area to open as a result of an actuating pressure. For the same reason, a relatively low actuating pressure is needed to open the movable element 264. To ensure a complete closing of the valve element 250 when the actuating pressure is removed, for example, resilient elements may be added around the slits 262 to further bias the movable element 264 to the closed position. In the exemplary embodiment shown in
In the exemplary embodiment shown, the slits 312 and 314 do not touch one another so that the movable elements 320 are continuous with portions 322 of the flexible disk 320. In different embodiments, the slits 312 and 314 may intersect with one another, breaking the flexible disk 320 into additional distinct moving elements. In the exemplary embodiment shown, the movable elements 320 are unconstrained along the slits 312, 314, but are constrained in the region between the slits by being continuous with the portions 322 of the flexible disk 320. The addition of the Y-configured slits permits the movable elements 320 to open to a greater extent under an equivalent actuating pressure, while retaining a biasing force sufficient to completely close the opening when the actuating pressure is removed. To further bias the movable elements 320 toward the closed position, resilient elements 316, 318 may be added. As discussed in the context of previous embodiments, the resilient elements 316, 318 may be disposed in a substantially rectangular pattern around the slits 312, 314 to control the deflection and closure of the movable elements 320 in two directions substantially perpendicular to one another. The resilient elements 316, 318 may form a completely rectangular enclosure as shown in
A different exemplary embodiment according to the present invention is depicted in
As was the case in other the exemplary embodiments of the invention, the resilience of the movable elements 364, 366 is controlled to ensure that the valve element 350 fully closes once the actuating pressure is removed—even after remaining open for extended periods of time (i.e., to ensure that the valve is not subject to “memory” effects). Accordingly, the resilience of the material forming the movable elements 364, 366 is preferably selected and additional resilient elements are incorporated into the flexible disk 360, as described above with respect to other embodiments, based on the conditions to which the valve element 350 is to be subjected to ensure that such plastic deformation does not result in degraded performance over time.
The present invention has been described with reference to specific exemplary embodiments. Those skilled in the art will understand that changes may be made in details, particularly in matters of shape, size, material and arrangement of parts. For example, different flexible disks may be used to form the pressure sensitive valve, and may have different dimensions than those shown. Accordingly, various modifications and changes may be made to the embodiments without departing from the broadest scope of the invention as set forth in the claims that follow. The specifications and drawings are, therefore, to be regarded in an illustrative rather than a restrictive sense.
This application is a Continuation application of U.S. patent application Ser. No. 10/608,660 filed on Jun. 27, 2003 entitled “Pressure Actuated Valve with Improved Biasing Member”. The entire disclosure of this prior application is considered as being part of the disclosure of the accompanying application and hereby expressly incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
2720881 | Weaver et al. | Oct 1955 | A |
2755060 | Raymond | Jul 1956 | A |
3113586 | Edmark | Dec 1963 | A |
3159175 | MacMillan | Dec 1964 | A |
3159176 | Russell et al. | Dec 1964 | A |
3477438 | Allen et al. | Nov 1969 | A |
3514438 | Nelsen et al. | May 1970 | A |
3525357 | Koreski | Aug 1970 | A |
3621557 | Cushman et al. | Nov 1971 | A |
3669323 | Harker et al. | Jun 1972 | A |
3673612 | Merrill et al. | Jul 1972 | A |
3674183 | Venable et al. | Jul 1972 | A |
3710942 | Rosenberg | Jan 1973 | A |
3788327 | Donowitz et al. | Jan 1974 | A |
3811466 | Ohringer | May 1974 | A |
3955594 | Snow | May 1976 | A |
4072146 | Howes | Feb 1978 | A |
4142525 | Binard et al. | Mar 1979 | A |
4143853 | Abramson | Mar 1979 | A |
4244379 | Smith | Jan 1981 | A |
4387879 | Tauschinski | Jun 1983 | A |
4405316 | Mittleman | Sep 1983 | A |
4434810 | Atkinson | Mar 1984 | A |
4447237 | Frisch et al. | May 1984 | A |
4468224 | Enzmann et al. | Aug 1984 | A |
4502502 | Krug | Mar 1985 | A |
4524805 | Hoffman | Jun 1985 | A |
4543087 | Sommercorn et al. | Sep 1985 | A |
4552553 | Schulte et al. | Nov 1985 | A |
4610665 | Matsumoto et al. | Sep 1986 | A |
4616768 | Flier | Oct 1986 | A |
4646945 | Steiner et al. | Mar 1987 | A |
4673393 | Suzuki et al. | Jun 1987 | A |
4681572 | Tokarz et al. | Jul 1987 | A |
4692146 | Hilger | Sep 1987 | A |
4722725 | Sawyer et al. | Feb 1988 | A |
4790832 | Lopez | Dec 1988 | A |
4798594 | Hillstead | Jan 1989 | A |
4801297 | Mueller | Jan 1989 | A |
4908028 | Colon et al. | Mar 1990 | A |
4944726 | Hilal et al. | Jul 1990 | A |
4946448 | Richmond | Aug 1990 | A |
4960412 | Fink | Oct 1990 | A |
5000745 | Guest et al. | Mar 1991 | A |
5009391 | Steigerwald | Apr 1991 | A |
5030210 | Alchas et al. | Jul 1991 | A |
5084015 | Moriuchi | Jan 1992 | A |
5098405 | Peterson et al. | Mar 1992 | A |
5125893 | Dryden | Jun 1992 | A |
5147332 | Moorehead | Sep 1992 | A |
5149327 | Oshiyama | Sep 1992 | A |
5167638 | Felix et al. | Dec 1992 | A |
5169393 | Moorehead et al. | Dec 1992 | A |
5176652 | Littrell | Jan 1993 | A |
5176662 | Bartholomew et al. | Jan 1993 | A |
5201722 | Moorehead et al. | Apr 1993 | A |
5205834 | Moorehead et al. | Apr 1993 | A |
5249598 | Schmidt | Oct 1993 | A |
5253765 | Moorehead et al. | Oct 1993 | A |
5324274 | Martin | Jun 1994 | A |
5330424 | Palmer et al. | Jul 1994 | A |
5336203 | Goldhardt et al. | Aug 1994 | A |
5360407 | Leonard et al. | Nov 1994 | A |
5370624 | Edwards et al. | Dec 1994 | A |
5396925 | Poli et al. | Mar 1995 | A |
5399168 | Wadsworth et al. | Mar 1995 | A |
5401255 | Sutherland et al. | Mar 1995 | A |
D357735 | McPhee | Apr 1995 | S |
5405340 | Fageol et al. | Apr 1995 | A |
5411491 | Goldhardt et al. | May 1995 | A |
5453097 | Paradis | Sep 1995 | A |
5454784 | Atkinson et al. | Oct 1995 | A |
5469805 | Gibbs et al. | Nov 1995 | A |
5470305 | Arnett et al. | Nov 1995 | A |
5484420 | Russo | Jan 1996 | A |
5542923 | Ensminger et al. | Aug 1996 | A |
5554136 | Luther | Sep 1996 | A |
5562618 | Cai et al. | Oct 1996 | A |
5571093 | Cruz et al. | Nov 1996 | A |
5575769 | Vaillancourt et al. | Nov 1996 | A |
5624395 | Mikhail et al. | Apr 1997 | A |
5637099 | Durdin et al. | Jun 1997 | A |
5667500 | Palmer et al. | Sep 1997 | A |
5707357 | Mikhail et al. | Jan 1998 | A |
5743873 | Cai et al. | Apr 1998 | A |
5743884 | Hasson et al. | Apr 1998 | A |
5743894 | Swisher | Apr 1998 | A |
5752938 | Flatland et al. | May 1998 | A |
5803078 | Brauner | Sep 1998 | A |
5807349 | Person et al. | Sep 1998 | A |
5810789 | Powers et al. | Sep 1998 | A |
5843044 | Moorehead | Dec 1998 | A |
5853397 | Shemesh et al. | Dec 1998 | A |
5865308 | Qin et al. | Feb 1999 | A |
5944698 | Fischer et al. | Aug 1999 | A |
5984902 | Moorehead | Nov 1999 | A |
5989233 | Yoon | Nov 1999 | A |
6033393 | Balbierz et al. | Mar 2000 | A |
6045734 | Luther et al. | Apr 2000 | A |
6050934 | Mikhail et al. | Apr 2000 | A |
6056717 | Finch et al. | May 2000 | A |
6062244 | Arkans | May 2000 | A |
6092551 | Bennett | Jul 2000 | A |
6120483 | Davey et al. | Sep 2000 | A |
6152909 | Jones et al. | Nov 2000 | A |
6210366 | Sanfilippo | Apr 2001 | B1 |
6227200 | Crump et al. | May 2001 | B1 |
6270489 | Wise et al. | Aug 2001 | B1 |
6306124 | Jones et al. | Oct 2001 | B1 |
6364861 | Feith et al. | Apr 2002 | B1 |
6364867 | Wise et al. | Apr 2002 | B2 |
6375637 | Campbell et al. | Apr 2002 | B1 |
6436077 | Davey et al. | Aug 2002 | B1 |
6442415 | Bis et al. | Aug 2002 | B1 |
6446671 | Armenia et al. | Sep 2002 | B2 |
6508791 | Guerrero | Jan 2003 | B1 |
6551270 | Bimbo et al. | Apr 2003 | B1 |
6610031 | Chin | Aug 2003 | B1 |
6726063 | Stull et al. | Apr 2004 | B2 |
6786884 | DeCant et al. | Sep 2004 | B1 |
6874999 | Dai et al. | Apr 2005 | B2 |
6953450 | Baldwin et al. | Oct 2005 | B2 |
6994314 | Garnier et al. | Feb 2006 | B2 |
7081106 | Guo et al. | Jul 2006 | B1 |
7252652 | Moorehead et al. | Aug 2007 | B2 |
7291133 | Kindler et al. | Nov 2007 | B1 |
7316655 | Garibotto et al. | Jan 2008 | B2 |
7435236 | Weaver et al. | Oct 2008 | B2 |
7601141 | Dikeman et al. | Oct 2009 | B2 |
7637893 | Christensen et al. | Dec 2009 | B2 |
7758541 | Wallace et al. | Jul 2010 | B2 |
20010023333 | Wisse et al. | Sep 2001 | A1 |
20010037079 | Burbank et al. | Nov 2001 | A1 |
20020010425 | Guo et al. | Jan 2002 | A1 |
20020016584 | Wise et al. | Feb 2002 | A1 |
20020121530 | Socier | Sep 2002 | A1 |
20020165492 | Davey et al. | Nov 2002 | A1 |
20020193752 | Lynn | Dec 2002 | A1 |
20030122095 | Wilson et al. | Jul 2003 | A1 |
20040034324 | Seese et al. | Feb 2004 | A1 |
20040064128 | Raijman et al. | Apr 2004 | A1 |
20040102738 | Dikeman | May 2004 | A1 |
20040108479 | Garnier et al. | Jun 2004 | A1 |
20040186444 | Daly et al. | Sep 2004 | A1 |
20040193119 | Canaud et al. | Sep 2004 | A1 |
20040210194 | Bonnette et al. | Oct 2004 | A1 |
20040267185 | Weaver et al. | Dec 2004 | A1 |
20050010176 | Dikeman et al. | Jan 2005 | A1 |
20050027261 | Weaver et al. | Feb 2005 | A1 |
20050043703 | Nordgren | Feb 2005 | A1 |
20050049555 | Moorehead et al. | Mar 2005 | A1 |
20050149116 | Edwards et al. | Jul 2005 | A1 |
20050171490 | Weaver et al. | Aug 2005 | A1 |
20050171510 | DiCarlo et al. | Aug 2005 | A1 |
20050283122 | Nordgren | Dec 2005 | A1 |
20060129092 | Hanlon et al. | Jun 2006 | A1 |
20060135949 | Rome et al. | Jun 2006 | A1 |
20060149211 | Simpson et al. | Jul 2006 | A1 |
20070161940 | Blanchard et al. | Jul 2007 | A1 |
20070161970 | Moorehead et al. | Jul 2007 | A1 |
20070276313 | Moorehead et al. | Nov 2007 | A1 |
20080108956 | Lynn et al. | May 2008 | A1 |
20090292252 | Lareau et al. | Nov 2009 | A1 |
Number | Date | Country |
---|---|---|
20208420 | Oct 2002 | DE |
0128625 | Dec 1984 | EP |
198962 | Oct 1986 | EP |
0337617 | Oct 1989 | EP |
0864336 | Sep 1998 | EP |
0930082 | Jul 1999 | EP |
1016431 | Jul 2000 | EP |
2508008 | Dec 1982 | FR |
2718969 | Oct 1995 | FR |
966137 | Aug 1964 | GB |
2102398 | Feb 1983 | GB |
59133877 | Aug 1984 | JP |
06121499 | Apr 1994 | JP |
9038197 | Feb 1997 | JP |
WO-8902764 | Apr 1989 | WO |
WO-9206732 | Apr 1992 | WO |
WO-9516480 | Jun 1995 | WO |
WO-9617190 | Jun 1996 | WO |
WO 9623158 | Aug 1996 | WO |
WO-9641649 | Dec 1996 | WO |
WO-9723255 | Jul 1997 | WO |
WO-9726931 | Jul 1997 | WO |
WO-9822178 | May 1998 | WO |
WO-9942166 | Aug 1999 | WO |
WO-0006230 | Feb 2000 | WO |
WO-0044419 | Aug 2000 | WO |
WO-0174434 | Oct 2001 | WO |
WO-03084832 | Oct 2003 | WO |
WO-2005023355 | Mar 2005 | WO |
WO-2008089985 | Jul 2008 | WO |
Entry |
---|
elastomer. (2003). In The Macmillan Encyclopedia. Basingstoke, Hampshire: Macmillan Publishers Ltd. Retrieved Feb. 23, 2009, from http://www.credoreference.com/entry/3298087/. |
Asch, “Venous access: options, approaches and issues,” Can Assoc. Radiol J., vol. 52, No. 3 pp. 153-164 (2001). |
Herts et al., “Power injection of contrast media using central venous catheters: feasibility, safety, and efficacy,” AJR Am. J. Roentgenol., vol. 176, No. 2, pp. 447-453 (2001). |
Roth et al., “Influence of radiographic contrast media viscosity to flow through coronary angiographic catheters,” Cathet. Cardiovasc. Diagn., vol. 22, No. 4, pp. 290-294 (1991). |
Carlson et al., “Safety considerations in the power injection of contrast media via central venous catheters during computered tomogrphic examinations,” Invest. Radiol., vol. 27, No. 5, p. 337-340 (1992). |
Kaste et al., “Safe use of powr injectors with central and peripheral venous access devices for pediatrict CT,” Pediatr. Radiol., vol. 26, No. 8, pp. 449-501 (1996). |
Herts et al., “Power injection of intravenous contrast material through central venous catheters for CT: in vitro evaluation,” Radiology, vol. 200, No. 3, pp. 731-735 (1996). |
Rivitz et al., “Power injection of peripherally inserted central catheters,” J. Vasc. Interv. Radiol., vol. 8, No. 5, pp. 857-863 (1997). |
Rogalla et al., Safe and easy power injection of contrast material through a central line, Eur. Radiol., vol. 8, No. 1, pp. 148-149 (1998). |
Williamson et al., “Assessing the adequacy of peripherally inserted central catheters for power injection of intravenous contrast agents for CT,” J. Comput. Assist. Tomogr., vol. 25, No. 6, pp. 932-937 (2001). |
Chahous et al., “Randomized comparison of coronary angiography using 4F catheters: 4F manual versus ‘Acisted’ power injection technique,” Catheter Cardiovasc. Interv., vol. 53, No. 2, pp. 221-224 (2001). |
Walsh et al., “Effect of contrast agent viscosity and injection flow velocity on bolus injection pressures for peripheral venous injection in first-pass myocardial perfusion studies,” Technol. Health Care, vol. 10, No. 1, pp. 57-63 (2002). |
Saito et al., “Diagnostic brachial coronary arteriography using a power-assisted injector and 4 French catheters with new shamps,” J. Invasive Cardiol., vol. 9, No. 7, pp. 461-468 (1997). |
Examination Report mailed Apr. 7, 2006 for European Patent Application No. 04751644.8 (5 pages). |
Examination Report mailed Apr. 6, 2010 for European Patent Application No. 04751644.8 (3 pages). |
English Translation of Office Action mailed Aug. 18, 2009 for Japanese Patent Application No. 2006-517107 (3 pages). |
English Translation of Office Action mailed Mar. 29, 2010 for Japanese Patent Application No. 2006-517107 (2 pages). |
English Translation of Office Action mailed Jan. 28, 2011 for Japanese Patent Application No. 2006-517107 (3 pages). |
International Search Report and Written Opinion mailed Nov. 5, 2004 for International Application No. PCT/US2004/014344 (9 pages). |
International Preliminary Report on Patentability mailed Jan. 3, 2006 for International Application No. PCT/US2004/014344 (7 pages). |
Number | Date | Country | |
---|---|---|---|
20090043261 A1 | Feb 2009 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10608660 | Jun 2003 | US |
Child | 12250920 | US |